Details for New Drug Application (NDA): 206927
✉ Email this page to a colleague
The generic ingredient in BORTEZOMIB is bortezomib. There are twenty drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the bortezomib profile page.
Summary for 206927
Tradename: | BORTEZOMIB |
Applicant: | Dr Reddys |
Ingredient: | bortezomib |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 206927
Mechanism of Action | Proteasome Inhibitors |
Medical Subject Heading (MeSH) Categories for 206927
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | POWDER;INTRAVENOUS | Strength | 3.5MG/VIAL | ||||
Approval Date: | Oct 4, 2019 | TE: | RLD: | No |
Complete Access Available with Subscription